Internal Travenol correspondence from A Cameron to C Chard re Meeting at DHSS with DRS Fowler and Purves. This meeting was to discuss issues relating to the Hyland Therapeutic Ranges and other regulatory areas. Both DHSS and NIBSC expressed concern about the dual labelling of Albumin solutions 5% such as PPF and buminate.